Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China

Table 1

Baseline characteristics of the study population.

Variables	Total ()
Demographic
Age (years)	39 (31.2, 47)
Male	101 (63.13%)
Hepatitis virus
HBeAg positivity	76 (47.5%)
Detectable HBV DNA	150 (93.75%)
HBV DNA (IU/mL)	11200 (445.25, 1056100)
Hematological parameters	41.7 (25, 67.6)
WBC count (109/L)	5.6 (4.7, 6.9)
RBC count (1012/L)	4.7 (4.3, 5.1)
Hemoglobin (g/L)	146 (130, 157)
MCV (fL)	91.1 (87.8, 94.1)
Platelet count (109/L)	175 (133, 207.5)
PDW (%)	13.2 (11.9, 14.7)
MPV (fL)	11.2 (10, 12)
Liver function markers
AST (8–40 IU/L)	32 (24, 45.2)
ALT (8–40 IU/L)	41.7 (25, 67.6)
GGT (5–54 IU/L)	35 (21, 64.3)
Fibrosis markers
GPR	0.39 (0.24, 0.73)
APRI	0.49 (0.30, 0.97)
Fib-4	1.16 (0.86, 1.93)
Histological (METAVIR scores)
0	34 (21.3%)
1	62 (38.8%)
2	18 (11.3%)
3	24 (15%)
4	22 (13.8%)